And here is what their managing director, James BcBrayer said;...

And here is what their managing director, James BcBrayer said; in their announcement to the ASX this morning 2nd October....

“USFDA approval for Technegas has been achieved through the persistence and the hard work of our highly skilled global team along with the unwavering support of our Board and shareholders. Importantly, USFDA approval has also established a platform for maximising the clinical use of Technegas across a wide range of respiratory applications going forward”.“While FDA approval for Technegas is a major milestone for Cyclopharm, our ability to now make this technology available to US clinicians and to the patients they serve, is where the key significance lies. I look forward to providing you with regular updates on the US rollout of Technegas as we proceed with this exciting new phase for the company.”